Jacobs Levy Equity Management
AGL icon

Jacobs Levy Equity Management’s Agilon Health AGL Stock Holding History

Jacobs Levy Equity Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.35M Buy
296,552
+135,033
+84% +$2.18M 0.01% 557
2025
Q4 		$2.78M Buy
161,519
+37,525
+30% +$728K 0.01% 526
2025
Q3 		$3.19M Buy
123,994
+50,547
+69% +$1.91M 0.01% 505
2025
Q2 		$4.22M Buy
+73,447
New +$5.89M 0.02% 475

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management's AGL Position: Q1 2026 in Review

Jacobs Levy Equity Management increased its Agilon Health (AGL) stake by 84% in Q1 2026, buying an estimated $2.18M and bringing the position to 296,552 shares worth $2.35M. The position accounts for 0.01% of the portfolio, ranked #557.

Jacobs Levy Equity Management first reported a position in AGL in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.22M in Q2 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Jacobs Levy Equity Management held 296,552 shares of Agilon Health worth $2.35M as of Q1 2026.
  • Jacobs Levy Equity Management bought 135,033 Agilon Health shares in Q1 2026, an estimated $2.18M.
  • Agilon Health made up 0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #557 holding.
  • Jacobs Levy Equity Management first reported a position in Agilon Health in Q2 2025 and has held it in 4 quarters since.
  • Jacobs Levy Equity Management's Agilon Health position peaked at $4.22M in Q2 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.